chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started to feel a little funny a few hours after the vaccine then I started coughing and both of my eyes became bright red and felt heavy, my upper lip may have been a little swollen. I took my temp, no fever. The cough/respiratory issues subsided around 6pm that same evening but my red eyes remained. Yesterday, I woke up with super red eyes,  was also stuffy and had a headache that turned into a migraine later in the day that acetaminophen wouldn't touch. This morning when I woke up my headache was gone and my eyes were barely red...all of my symptoms were gone by early afternoon. No pregnancy history.
pt states that the day after receiving the covid vax she was having flu like symptoms.  She had itchy hives on her head that seam to come and go.  On 2/18/2021 to 2/22/2021 she had a solid red itchy burning rash on both ears.  On 2/23/2021 the rash on the ears moved to her face.  On 2/22/2021 she had a virtual doctor appt.  She was told to take antihistamine and hydrocortisone. On 2/24/2021 the rash was getting worse so she visited her PCP thought she was having an allergic reaction to the vax and was told to continue the hydrocortisone cream and to come back if it didnt get better.  Pt still today 2/25/2021 has the rash on her face and some on her neck that she has aggravated it by scratching it in her sleep.
Information has been received from a registered nurse concerning a female who on 07-FEB-2008 was vaccinated IM in the left deltoid with the first dose of GARDASIL (lot# 655327/1287U).  In approximately March 2008, the patient developed irregular menstrual cycles.  In the last couple of months, the patient has been having about 2 periods a month compared to her usual 1 cycle monthly.  The patient sought unspecified medical attention by contacting her physician's office.  The patient's irregular menstrual cycles have persisted.  There are no other details.  Additional information has been requested.
This spontaneous report was received from a licensed practical nurse refers to a 4 month old female patient without drug reactions and allergies. The patient did not have any relevant medical history. On 18-AUG-2014 the patient was vaccinated with ROTATEQ, oral, lot # K007243, expiration date: 13-DEC-2015 (dose was not reported). On 03-NOV-2014 the patient received another dose of ROTATEQ oral (dose and lot # not reported). There were no concomitant medications. After the ROTATEQ dose on 03-NOV-2014, the patient vomited. Thus, part of the vaccine, ROTATEQ dose may have been lost. The patient did not receive any treatment for the adverse event. There were not laboratory diagnostics studies performed. The outcome of patient vomited was reported as recovered/resolved on 03-NOV-2014. Additional information has been requested.
Aches, Extreme chills(Chattering Teeth), no strength in legs.Could not stand up.EMS took him to hospital at 6:30 PM 2/20/2021. Extremely dehydrated. He was discharged the next afternoon at4 PM. Diagnosis: Elevated lactic acid level and fever after COVID -19 vaccination.
Initial report was retrieved from a scientific literature on 12 September 2013. This case is linked to case numbers 2012-10777, 2013-09581, 2013-09583, 2013-09584, 2013-09585 and 2013-09603. A pregnant female patient (age range of 25-35 years) had received an injection of FLUZONE Intradermal (lot number, route, site and date of administration not reported) and an unspecified amount of time later experienced syncope. Outcome was not reported. Documents held by sender: None.
Information has been received from a registered nurse concerning a 7-year-old male with right lymphadenitis at the time of vaccination with no preexisting allergies who on 24-OCT-2000 was vaccinated with his first dose of varicella virus vaccine live (Oka/Merck). Concomitant therapy included Augmentin. On 10-MAR-2007, the patient experienced a rash described as "five papules on the face to vesicles." There was no fever. No laboratory or diagnostic tests were performed. On 16-MAR-2007, the patient recovered from papular and vesicular rash. Follow up information was received from a registered nurse, who reported that on an unspecified date a "quick test" for strep throat was performed, which was negative and the agar plate was negative at 24 and 48 hours. No other tests were done. No further information expected.
Mom took son with her to a Pfizer clinic.  PT went through screening process and was administered an adult Pfizer as this was a booster clinic.  Mom made aware of med error while waiting to be discharged from the clinic.  Clinic educated parents to follow up with PCP, PCP encouraged parents to follow up with DOH.  Dad called into DOH to inquire what to do next with dosing.  Dad reports that patients experienced typical side effects of fatigue, HA, and sore arm.  Dad asking questions of what to look and what to be concerned about because child was administered the wrong formulation.  DOH physician followed up with education with family.  11/22/2021: Spoke with clinic, Recommended that they complete a VAERS form and educated on how to do that, verbalized understanding.   She reported that patient's mom signed him up for the clinic and he was administered the dose by a new nurse who asked his age after administration.
Patient developed "burning pain in left breast" the day after vaccination was given. This persisted and developed into a painful rash around the trunk but no blisters. The patient visited an urgent care facility where a provider advised that it was a possible shingles outbreak, and was given triamcinolone, bacitracin, valacylovir, and hydrocodone/acetaminophen to treat the symptoms.
heartrate 90-100 bpm; fever; chills; arm hurts; nausea; This spontaneous case was reported by a nurse and describes the occurrence of HEART RATE INCREASED (heartrate 90-100 bpm), PYREXIA (fever), CHILLS (chills), VACCINATION SITE PAIN (arm hurts) and NAUSEA (nausea) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Feb-2021 at 1:00 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEART RATE INCREASED (heartrate 90-100 bpm), PYREXIA (fever), CHILLS (chills), VACCINATION SITE PAIN (arm hurts) and NAUSEA (nausea). At the time of the report, HEART RATE INCREASED (heartrate 90-100 bpm), PYREXIA (fever), CHILLS (chills), VACCINATION SITE PAIN (arm hurts) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 f 102 F. On an unknown date, Heart rate: 90-100 90-100 beats per minute.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was taking beta blocker for her heart.
Presented 5/13/21 to PCP office with a large area of erythema, hot to the touch, started 3 days after second Moderna vaccine, had smaller scale reaction to the first vaccine. No pain in arm.
ARNP for Dr reported-symptoms of chicken pox type rash on trunk and arms-she did not look at legs. No rash in mouth or ears. No fever or runny nose, did have ear infection and was given Zithromax. No loss of appetite, expect full recovery. Follow up on 12/02/03: "Sorry I missed this and needed to write better for the name spelling."
Sudden cardiac death.  After vaccine patient experienced headache, chills, fatigue, chest pain and did not seek medical care. He had a witnessed cardiac arrest less than 3 days after vaccine #2.
This spontaneous report was received from a licensed practical nurse and refers to a female patient of unknown age. Pertinent medical history, concurrent conditions and drug reactions or allergies were unknown. On an unknown date, when the patient was a child (reported as "vaccinated as a child"), she was vaccinated with a dose series of hepatitis b vaccine (manufacturer unknown) (batch/lot number, expiration date, dose and frequency) intramuscularly. Other suspect therapies or concomitant medications were unknown. The reporter stated that on an unknown date the patient had a lab result of a negative titer for Hepatitis B. No adverse effects were reported. The outcome of the above mentioned event and the causality between the event and hepatitis b vaccine (manufacturer unknown) were unknown at the time of the report. It was reported that the patient did not seek medical attention. No product quality complaint was involved. Additional information has been requested.
102 temp, chills, muscle weakness (severe, I fell and was not able to get up and was transported to local ER)  headache, weakness, muscle pain in neck and back.
On 10/01/2022, I was travelling and had some coughing and sneezing. When I got home, I felt lethargic. I took a COVID-19 test, which was positive. I only felt bad for around two days. I continued to test positive for around five days. I spoke with my doctor who prescribed PAXLOVID.
Felt a lot of heat in her body; Hot flashes; Had a dry mouth; Felt lousy; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Felt a lot of heat in her body), HOT FLUSH (Hot flashes), DRY MOUTH (Had a dry mouth) and MALAISE (Felt lousy) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in 2020.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced FEELING HOT (Felt a lot of heat in her body), HOT FLUSH (Hot flashes), DRY MOUTH (Had a dry mouth) and MALAISE (Felt lousy). At the time of the report, FEELING HOT (Felt a lot of heat in her body), HOT FLUSH (Hot flashes), DRY MOUTH (Had a dry mouth) and MALAISE (Felt lousy) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications were not provided. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Outcome of events provided
My daughter has eczema but has never had a flare up anywhere near this bad. She now has a number of open sores on her wrists, elbows, and face. The spots on her face are continuing to appear in spite of my applying hydrocortisone 2x per day.
pt recvd 1st dose of MMR vax on 3OCT79 w/no noted problems; On 30AUG91 pt recvd booster dose of MMR & immed following vax exp faint feeling, paleness & a h/a; 30-45 mins later pt recovered; no further details were provided;
A 35 year old female, had occupational exposure to a rabid cat through scratches on her hands. She was started on post-exposure therapy and received first 2 doses of RabAvert on 6/26/03 and 6/30/03, respectively. On 7/3/03, the patient called her physician to report a slight numbness in her face. She was seen on 7/4/03, which was to be her 3rd scheduled visit. She reported an increase in facial numbness. She was told to discontinue vaccine series. The patient had a significant history of facial paralysis at age 10. By the time she was seen again by family practice professionals on 7/9/03, her facial numbness had spontaneously remitted. She was given dose #3 on 7/9/03 and told to return for remaining injections. She was advised to have DepoMedrol administered with each immunization. She completed the course of RabAvert without further sequela of facial numbness. (OMIC)
A day after receiving Td booster, felt sore and achy to left upper arm and noticed tenderness in left axilla.
Fever, vomiting, diarrhea, fatigue, sore muscles developed within 12 hours of vaccine administration and were improving at approximately 24 hours later.
MD rpt pt recv 1st dose varivax 8/22/95 & in 3/98 pt exp ``5-6 chickenpox''
Breakthrough COVID case.  I tested positive on 02-01-2022 and had symptoms through 02-05-2022.
9DEC96 pt stated gets a red ring approx the size of 1/2 of a pencil eraser which itches @ site of flu shot;It had a small scab @ the center;It itches every day though;not cont just @ various times throughout the day;site sore & itchy;
extreme shortness of breath,  chest discomfort, edema in feet, ongoing since May 2nd.
Patient received first dose of Pfizer vaccine (lot EW0170) on 4/24/21 at University and received 2nd dose of Pfizer vaccine (lot EW0182) on 5/15/21 also at University. Came to hospital ED on 5/16 AM with diagnosis of acute chest pain, acute dehydration, and adverse reaction to vaccine administration. Was discharged to home and returned to ED on 5/17/21 for continued chest pain (central, throbbing, non-radiating chest pain). Medical tests and laboratory results revealed elevated troponin level (1.546 at peak, then declined to 0.585 prior to discharge home). Patient was admitted to PICU for close monitoring. CT angiogram of chest was negative, chest x-ray was negative, EKG showed normal sinus rhythm, echocardiogram was done and it was a normal study. Dr. discussed with the cardiology department at Hospital. Possible myocarditis due to vaccine. COVID-10 IgG IgM antibodies were positive for the patient which indicates good efficacy of the vaccine. Patient to have follow-up with outpatient pediatric cardiology Dr.   Discussion with father on 5/20/21 indicates that patient's symptoms were improving.
She got sick; Swelling in her left arm at the injection site the size of a tennis ball, like a knot.; Swelling in her left arm at the injection site; fever; Chills; Injection site was red; Injection was sore; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (She got sick), VACCINATION SITE MASS (Swelling in her left arm at the injection site the size of a tennis ball, like a knot.), VACCINATION SITE SWELLING (Swelling in her left arm at the injection site), PYREXIA (fever) and CHILLS (Chills) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939906) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Oct-2021, the patient experienced ILLNESS (She got sick), VACCINATION SITE MASS (Swelling in her left arm at the injection site the size of a tennis ball, like a knot.), VACCINATION SITE SWELLING (Swelling in her left arm at the injection site), PYREXIA (fever), CHILLS (Chills), INJECTION SITE ERYTHEMA (Injection site was red) and VACCINATION SITE PAIN (Injection was sore). At the time of the report, ILLNESS (She got sick), VACCINATION SITE MASS (Swelling in her left arm at the injection site the size of a tennis ball, like a knot.), VACCINATION SITE SWELLING (Swelling in her left arm at the injection site), PYREXIA (fever), CHILLS (Chills), INJECTION SITE ERYTHEMA (Injection site was red) and VACCINATION SITE PAIN (Injection was sore) outcome was unknown.            No concomitant and treatment medications were provided. On the same evening (25-oct-2021), the patient got sick. The patient had a fever and chills, welling in her left arm at the injection site the size of a tennis ball, like a knot. The patient stated the injection site is red and sore.
Case number PHEH2012US021502 is an initial spontaneous report received from a pharmacist on 23 Oct 2012: This report refers to a patient of unknown age group and gender. This patient was given MenA lyophilized conjugate component of MENVEO (batch number: unknown) intramuscularly reconstituted with sterile water, instead of MenCYW component on an unspecified date. No adverse event was reported following this administration error (wrong solution used in drug reconstitution).
While sitting on a chair about 8 minutes after her vaccination, patient mentioned that she felt nauseous. Immediately after she had a syncopal episode and was unresponsive for about 1 minute. We immediately called 911, lay her flat and raised her legs. She became responsive and was alert and oriented X  3. We were unable to get a BP reading but her color was improving and she remained alert. We repositioned her in a supine position and she had another syncopal episode. We raised her legs again and she improved immediately. EMS arrived shortly after. She remained alert and responsive  and was evaluated for about an hour and released to her spouse. She didn't want to be evaluated at the hospital. She made record of having a similar episode during a procedure at her doctor's office.
Lot number for the first dose was EK5730. After receiving the 2nd dose on the 01/11/2021 went to lunch and in the evening started feeling nausea and was throwing and abdominal pain. Went to work sick Tuesday and Wednesday low grade fever, nausea and abdominal pain, wasn't eating was to sick to eat. Thursday early morning hours the pain was unbearable so she went to the ER and the cat scan.  It was determined that she had appendicitis  and they removed my appendix same day. Feels so much better now.
I had arm soreness about three hours after that was progressively worse the first three days then started going away. On the fourth day and I woke up sneezing and could not stop. I had a lot of nasal congestion and a low grade fever (100.8), I also had a lot of fatigue. I had a little bit of a cough as well. This all lasted for about five days.  I also got a Covid test and that came back negative.
Pediatric dose was given to adults mistakenly; Moderna COVID-19 vaccine administered to patients post temperature excursion; Moderna COVID-19 vaccine administered to patients post temperature excursion; No adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered to patients post temperature excursion) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR5186C) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered to patients post temperature excursion) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion), POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered to patients post temperature excursion) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for WRONG PRODUCT ADMINISTERED (Pediatric dose was given to adults mistakenly), PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna COVID-19 vaccine administered to patients post temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (Moderna COVID-19 vaccine administered to patients post temperature excursion).    Concomitant product use was not provided by the reporter.  It was reported there was a temperature excursion between 26May2022 to 30Sep2022 and lot AR5186C was affected between 08Sep2022 to 27Sep2022. AR5186C was previously reported. Pediatric dose was given to adults mistakenly and were reported to CDPH, VAERS, CAIR and each patient that received the error dose, with instructions to re-vaccinate 2 months from the initial error dose.   No treatment information was provided.  This case contains information for the 79th of 104 adult patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2022-669791 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-669791:Master Case
tightening of jaw right p/inj as told by patient;vaccine administered 6months ago;unk duration of sx;
This spontaneous report was received from a 53 years old female consumer regarding herself. Drug reactions included codeine containing products caused vomiting in the patient. On 06-NOV-2012, the patient was vaccinated subcutaneously with 0.65 ZOSTAVAX (lot # and expiry not reported). Secondary suspect therapy included influenza virus vaccine (manufacturer unknown) (lot #, route, dose and expiry not reported) given in the opposite arm on an unknown date. No concomitant medications were reported. On 07-NOV-2012 ("8-10 hours after the vaccine"), the patient developed chills for 16 hours after receiving ZOSTAVAX and also developed a very large "beet red" at the injection site. She stated that the injection site reaction was very warm to touch and approximately 6 inches by 5 inches and almost 1 inch deep. She described it as feeling like she had developed a cyst in the arm. The patient developed the chills starting the next day at 7AM after getting the vaccine and she then noticed the large injection site lump at that time. Aspirin was given as treatment. No laboratory diagnostic studies were performed. The outcome of chills, injection site reaction was very warm to touch and very large "beet red" knot at the injection site was reported as recovering. The patient had sought medical attention (unspecified). Additional information has been requested.